Skip to content

Menu

Cote Law PLLC logo
HomeAboutServicesBlogContact
Search
Close

DEA Chronicles

Drug Enforcement Administration Litigation & Compliance Issues

Diversion Fee Account

Subscribe to Diversion Fee Account

DEA Proposes 21% Increase in Registration Fees

By Larry P. Cote on March 12, 2020
Posted in Drug Policy

MoneyOn March 13, 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) seeking to raise registration fees on all DEA registrants. The proposed fees represent a 21% increase over current fees for all registrant categories. DEA indicates that the increase will provide an additional $318 million for the Diversion Fee Account over the next three fiscal years.

As discussed here, the Controlled Substances Act requires  that registration fees “shall be set at a level that ensures the recovery of the full costs of operating the various aspects of [the diversion control program].” 21 USC 886a(1)(C). DEA alleges in the NPRM that “[w]ithout an increase in registration fees, DEA will be unable to continue current operations” and will be unable to comply with the statutory mandate to recover all costs associated with managing the Diversion Control Program (DCP).

To support this doom and gloom prediction, DEA points to several reasons to justify the fee increase. They include, but are not limited to, the ongoing opioid crisis, the growing number of DEA registrants, a need for additional personnel at Headquarters and in Field Division Offices throughout the country, and additional requirements imposed by Congress in recent legislation. …
Continue Reading DEA Proposes 21% Increase in Registration Fees

About this Blog

Welcome to DEA Chronicles, a blog dedicated to helping you comply with DEA requirements for controlled substance distribution and prescription dispensing — and all that comes along with it.

Read More....

Stay Connected

RSS LinkedIn Twitter

Topics

Archives

Recent Posts

  • A Distributor’s Conundrum: When DEA and state law collide
  • Congress Seeks to Provide Clarity on Suspicious Order Monitoring
  • DEA Issues New/Old Guidance on Suspicious Order Monitoring
  • New Software Platform for Controlled Substance Compliance
  • DEA to Remove Exemptions for All Butalbital Products
Cote Law PLLC logo

1875 K Street, NW • Fourth Floor • Washington, D.C, 20006
Office: (202) 507-5784 • Cell: (703) 298-2258 • Fax: (202) 379-9524

RSS LinkedIn Twitter
Copyright © 2023, Cote Law PLLC. All Rights Reserved.
DisclaimerPrivacy Policy
Law blog design & platform by LexBlog LexBlog Logo